Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Endobronchial Valve Demonstrates Sustained Improvements for Severe Emphysema

Researchers found 'statistically significant improvements' in lung function, respiratory symptoms, and quality of life measures at 24 months.

Chronic Pulmonary Disorders

New Guidance for Treating Systemic Sclerosis-associated ILD

A new ATS clinical practice guideline recommends expanding antifibrotic treatment to all patients with systemic sclerosis associated with ILD, not just those with progressive disease.

Chronic Pulmonary Disorders

Health Canada OKs Trikafta for Younger Children With Cystic Fibrosis

Health Canada granted market authorization for the expanded use of Trikafta to include children with cystic fibrosis ages 2-5 years who have at least one copy of the F508del mutation in the CFTR gene.

Asthma

Severe Asthma Management

Severe asthma patients account for as much as 60% of all asthma healthcare costs, and proper management of severe disease is essential.

COPD

Suspected Bronchiectasis Tied to Higher Mortality, Even Without COPD

A study of current and former smokers found that suspected bronchiectasis is associated with a heightened risk of all-cause mortality, even without the presence of COPD.

Cystic fibrosis

Disease-causing Stem Cells Dominate Lungs of Advanced CF Patients

Five lung stem cell variants dominate the lungs of patients with advanced cystic fibrosis (CF), and these variants drive key aspects of CF pathology including inflammation, fibrosis, and mucin secretion, according to new research.

Pulmonary Fibrosis

Cleveland Clinic Pulmonologist Takes Helm at Pulmonary Fibrosis Foundation

The Pulmonary Fibrosis Foundation announced Franck Rahaghi, MD, MHS, FCCP, as its incoming president, CEO, and chief medical officer, effective Sept 15.

Allergies

Decongestant in Popular OTC Cold and Allergy Meds Doesn’t Work, FDA Panel Says

An FDA advisory committee determined that phenylephrine, common in brands like Benadryl and Mucinex, is ineffective as a nasal decongestant.

Other Chronic Diseases

Idrevloride in Hypertonic Saline Boosts Lung Function in Primary Ciliary Dyskinesia Patients

A new study finds that idrevloride in hypertonic saline is safe and associated with a significant improvement in lung function in individuals with primary ciliary dyskinesia when compared to hypertonic saline alone.